Academic Bibliography

 Search 200 years of publications by Ghent University researchers.
Advanced search
1 file | 238.33 KB
Add to list
  1. Search results
  2. Effects of IFN-β, leptin and simvasta...

Effects of IFN-β, leptin and simvastatin on LIF secretion by T lymphocytes of MS patients and healthy controls

Joris Vanderlocht, Jerome JA Hendriks, Koen Venken (UGent) , Piet Stinissen and Niels Hellings
(2006) JOURNAL OF NEUROIMMUNOLOGY. 177(1-2). p.189-200
Author
Organization
Keywords
neuroprotection, leukemia inhibitory factor, multiple sclerosis, immunotherapy, LEUKEMIA INHIBITORY FACTOR, CENTRAL-NERVOUS-SYSTEM, MULTIPLE-SCLEROSIS PATIENTS, CILIARY NEUROTROPHIC FACTOR, MYELIN BASIC-PROTEIN, AUTOIMMUNE ENCEPHALOMYELITIS, IN-VITRO, OLIGODENDROCYTE SURVIVAL, GROWTH-FACTOR, PROTECTIVE AUTOIMMUNITY

Downloads

  • Download
    (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 238.33 KB

Citation

Please use this url to cite or link to this publication:

MLA
Vanderlocht, Joris, et al. “Effects of IFN-β, Leptin and Simvastatin on LIF Secretion by T Lymphocytes of MS Patients and Healthy Controls.” JOURNAL OF NEUROIMMUNOLOGY, vol. 177, no. 1–2, 2006, pp. 189–200, doi:10.1016/j.jneuroim.2006.04.012.
APA
Vanderlocht, J., Hendriks, J. J., Venken, K., Stinissen, P., & Hellings, N. (2006). Effects of IFN-β, leptin and simvastatin on LIF secretion by T lymphocytes of MS patients and healthy controls. JOURNAL OF NEUROIMMUNOLOGY, 177(1–2), 189–200. https://doi.org/10.1016/j.jneuroim.2006.04.012
Chicago author-date
Vanderlocht, Joris, Jerome JA Hendriks, Koen Venken, Piet Stinissen, and Niels Hellings. 2006. “Effects of IFN-β, Leptin and Simvastatin on LIF Secretion by T Lymphocytes of MS Patients and Healthy Controls.” JOURNAL OF NEUROIMMUNOLOGY 177 (1–2): 189–200. https://doi.org/10.1016/j.jneuroim.2006.04.012.
Chicago author-date (all authors)
Vanderlocht, Joris, Jerome JA Hendriks, Koen Venken, Piet Stinissen, and Niels Hellings. 2006. “Effects of IFN-β, Leptin and Simvastatin on LIF Secretion by T Lymphocytes of MS Patients and Healthy Controls.” JOURNAL OF NEUROIMMUNOLOGY 177 (1–2): 189–200. doi:10.1016/j.jneuroim.2006.04.012.
Vancouver
1.
Vanderlocht J, Hendriks JJ, Venken K, Stinissen P, Hellings N. Effects of IFN-β, leptin and simvastatin on LIF secretion by T lymphocytes of MS patients and healthy controls. JOURNAL OF NEUROIMMUNOLOGY. 2006;177(1–2):189–200.
IEEE
[1]
J. Vanderlocht, J. J. Hendriks, K. Venken, P. Stinissen, and N. Hellings, “Effects of IFN-β, leptin and simvastatin on LIF secretion by T lymphocytes of MS patients and healthy controls,” JOURNAL OF NEUROIMMUNOLOGY, vol. 177, no. 1–2, pp. 189–200, 2006.
@article{2071169,
  author       = {{Vanderlocht, Joris and Hendriks, Jerome JA and Venken, Koen and Stinissen, Piet and Hellings, Niels}},
  issn         = {{0165-5728}},
  journal      = {{JOURNAL OF NEUROIMMUNOLOGY}},
  keywords     = {{neuroprotection,leukemia inhibitory factor,multiple sclerosis,immunotherapy,LEUKEMIA INHIBITORY FACTOR,CENTRAL-NERVOUS-SYSTEM,MULTIPLE-SCLEROSIS PATIENTS,CILIARY NEUROTROPHIC FACTOR,MYELIN BASIC-PROTEIN,AUTOIMMUNE ENCEPHALOMYELITIS,IN-VITRO,OLIGODENDROCYTE SURVIVAL,GROWTH-FACTOR,PROTECTIVE AUTOIMMUNITY}},
  language     = {{eng}},
  number       = {{1-2}},
  pages        = {{189--200}},
  title        = {{Effects of IFN-β, leptin and simvastatin on LIF secretion by T lymphocytes of MS patients and healthy controls}},
  url          = {{http://doi.org/10.1016/j.jneuroim.2006.04.012}},
  volume       = {{177}},
  year         = {{2006}},
}
Altmetric
View in Altmetric
Web of Science
Times cited: